KKR’s acquisition of a majority stake in NVC Lighting’s China business for US$794 million.
PAG Asia Capital in bidding for the acquisition of Yingde Gas for HK$11.3 billion.
Blackstone on its acquisition of SHP Group, a global cosmetics packaging manufacturer, for US$1.1 billion.
The investors’ consortium of ANTA, FountainVest and others on their all-cash tender offer for Amer Sports Corporation, a sporting goods company, for €4.6 billion.
Canada Pension Plan Investment Board, Warburg Pincus, Discovery Capital Management and Boyu Capital on their minority investment in Ant International Co. involving a total financing of US$14 billion.
Local Services Holding, the holding company of me and Koubei, on its equity financing by Alibaba, SoftBank, and other third party investors, involving a transaction price of US$3 billion.
KKR, TPG and GIC on their investment of US$1 billion in CICC, the first foreign-invested Chinese investment bank.
Carlyle on its investment in a minority stake in China Pacific Insurance Corporation for US$800 million.
TPG on its minority investment in Lenovo for US$350 million.
Blackstone on its US$600 million investment in China National BlueStar Group
Baring and other investors in relation to the privatization of Giant Interactive Group Inc., with a deal size of US$2.8 billion.
Focus Media on its privatization backed by private equity investors with a deal size of US$3.7 billion.
The investor consortium led by the chairman of eHi and MBK Partners to take private eHi Car Services for US$938 million.
Newbridge Capital on its acquisition of a controlling stake in Shenzhen Development Bank, the first acquisition of an A share-listed bank by a foreign investor.
A buyer consortium comprising Kunlun, Qihoo 360 and Golden Brick Capital Management on the US$575 million purchase of the Opera web browser, the core business of Opera, a Norway-listed internet company.
TPG on its US$460 million acquisition, together with Fosun Pharm, of Chindex International, Inc.
MBK Partners on its offer of US$253 million to buy Singapore-listed AsiaPharm, a company listed on the Singapore Stock Exchange.
Goldman Sachs and GIC on their investments in iKang Healthcare, the leading health inspection service provider in China, for approximately US$100 million.